Published in Health Risk Factor Week, November 6th, 2007
"Chemotherapy-naive patients were treated with docetaxel, either 3-weekly or weekly, in combination with cisplatin. All patients received adequate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.